Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Safety and Effectiveness of an All-Oral, Bedaquiline-Based, Shorter Treatment Regimen for Rifampicin-Resistant Tuberculosis in High Human Immunodeficiency Virus (HIV) Burden Rural South Africa: A Retrospective Cohort Analysis

1. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

   Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

   МақолаTuberculosis Research and EpidemiologyNew England Journal of Medicine20225 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.000002

2. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

   Animesh A. Sinha, Robert J. Klebe, Michael L. Rekart +22

   МақолаTuberculosis Research and EpidemiologyClinical Infectious Diseases20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.000230